Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 11 January 2008:
Vol. 319. no. 5860, pp. 154 - 156
DOI: 10.1126/science.319.5860.154

News Focus

CANCER IMMUNOLOGY:
Cancer's Bulwark Against Immune Attack: MDS Cells

Jean Marx

First noticed in the 1970s, myeloid-derived suppressor cells appear to play a key role in sustaining tumors; new methods of overcoming them are being tested.

Read the Full Text



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer.
S. Ostrand-Rosenberg and P. Sinha (2009)
J. Immunol. 182, 4499-4506
   Abstract »    Full Text »    PDF »
Potent induction of B- and T-cell immunity against human carcinoembryonic antigen-expressing tumors in human carcinoembryonic antigen transgenic mice mediated by direct lentivector injection.
S. Loisel-Meyer, T. Felizardo, J. Mariotti, M. E. Mossoba, J. E. Foley, R. Kammerer, N. Mizue, R. Keefe, J. A. McCart, W. Zimmermann, et al. (2009)
Mol. Cancer Ther. 8, 692-702
   Abstract »    Full Text »    PDF »
Transforming Growth Factor {beta}: Tumor Suppressor or Promoter? Are Host Immune Cells the Answer?.
L. Yang and H. L. Moses (2008)
Cancer Res. 68, 9107-9111
   Abstract »    Full Text »    PDF »
Myeloid-Derived Suppressor Cells in Cancer Cachexia Syndrome: A New Explanation for an Old Problem.
R. D. Winfield, M. J. Delano, K. Pande, P. O. Scumpia, D. LaFace, and L. L. Moldawer (2008)
JPEN J Parenter Enteral Nutr 32, 651-655
   Abstract »    Full Text »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)